Roy Moncayo

131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri, Francesco Giammarile, Cumali Aktolun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 295 citations

Oncologic Imaging, Medical Imaging, Procedure Guidelines +5

111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial

Irene Virgolini, K. E. Britton, John Buscombe et al. · Seminars in Nuclear Medicine · 2002 · 237 citations

Dna Sequencing, Medicine, Genetics +6

Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study

Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler et al. · BMC Endocrine Disorders · 2008 · 202 citations · Full text

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

Clemens Decristoforo, Stephen J. Mather, Witold Cholewiński et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 175 citations

111In-labelled Octreotide Derivatives, Somatostatin Receptor-positive Tumours, New 99Mtc-labelled Radiopharmaceutical +12

An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.

Michael Gabriel, Clemens Decristoforo, Eveline Donnemiller et al. · PubMed · 2003 · 169 citations